Abstract
This work reports a new acetonitrile (ACN)-solvated cocrystal of piroxicam (PRX) and succinic acid (SA), 2C(15)H(13)N(3)O(4)S center dot 0.5C(4)H(6)O(4)center dot C2H3N or PRX:SA:ACN (4:1:2), which adopts the triclinic space group P (1) over bar. The outcome of crystallization from ACN solution can be controlled by varying only the PRX:SA ratio, with a higher PRX:SA ratio in solution unexpectedly favouring a lower stoichiometric ratio in the solid product. In the new solvate, zwitterionic (Z) and non-ionized (NI) PRX molecules co-exist in the asymmetric unit. In contrast, the nonsolvated PRX-SA cocrystal contains only NI-type PRX molecules. The ACN molecule entrapped in PRX-SA center dot ACN does not form any hydrogen bonds with the surrounding molecules. In the solvated cocrystal, Z-type molecules form dimers linked by intermolecular N-H center dot center dot center dot O hydrogen bonds, whereas every pair of NI-type molecules is linked to SA via N-H center dot center dot center dot O and O-H center dot center dot center dot N hydrogen bonds. Thermogravimetry and differential scanning calorimetry suggest that thermal desolvation of the solvate sample occurs at 148 degrees C, and is followed by recrystallization, presumably of a multicomponent PRX-SA structure. Vibrational spectra (IR and Raman spectroscopy) of PRX-SA center dot ACN and PRX-SA are also used to demonstrate the ability of spectroscopic techniques to distinguish between NI-and Z-type PRX molecules in the solid state. Hence, vibrational spectroscopy can be used to distinguish the PRX-SA cocrystal and its ACN solvate.
Original language | English |
---|---|
Pages (from-to) | 29-37 |
Number of pages | 16 |
Journal | Acta Crystallographica Section C: Structural Chemistry |
Volume | 75 |
DOIs | |
Publication status | Published - 1 Jan 2019 |
Keywords / Materials (for Non-textual outputs)
- piroxicam
- succinic acid
- crystal structure
- cocrystal
- solvate
- BETA-CYCLODEXTRIN
- DRUG
- CRYSTALLIZATION
- CRYSTALS